In a recent development, AstraZeneca has acknowledged a rare but serious side effect linked to its COVID-19 vaccine, Covishield. This admission comes amidst a class-action lawsuit against the company in the UK High Court.
According to reports surfacing in late April 2024, AstraZeneca conceded in court documents submitted in February 2024 that Covishield can, in rare cases, cause Thrombosis with Thrombocytopenia syndrome (TTS). TTS is a condition characterized by blood clots forming in unusual locations along with a significant drop in blood platelet levels. These blood clots can be life-threatening, potentially leading to strokes, heart attacks, or pulmonary embolism (blood clots in the lungs).
This admission by AstraZeneca marks a shift from the company’s previous stance. In 2023, they denied any causal link between the vaccine and TTS. however, the recent court documents acknowledge the possibility, stating, “it is admitted that the AZ vaccine can, in very rare cases, cause TTS. The casual mechanism is not known.”
Also Read: Another New Covid Variant Is Spreading. Here’s What We Know About Omicron
The news has sparked concern, particularly in countries like India, where Covishield, manufactured by the Serum Institute of India under license from AstraZeneca, was widely used during the COVID-19 vaccination drive. Public health officials are urging people to be aware of the potential side effects and to seek immediate medical attention if they experience symptoms like severe headaches, blurred vision, shortness of breath, chest pain, or leg swelling after receiving the Covishiled vaccine.
The acknowledgement of this rare side effect by AstraZeneca doesn’t necessarily mean Covishield is unsafe. The benefits of the vaccine in preventing severe COVID-19 illness and death far outweigh the risks for the vast majority of people. However, it highlights the importance of transparency and open communication regarding vaccine safety.
The ongoing legal battle sheds light on the complexities of vaccine safety. While vaccines offer significant protection against viruses, there is always a possibility of rare side effects. The challenge lies in balancing the benefits of vaccination with the risks involved. Regulatory bodies like the World Health Organization (WHO) and national health agencies continuously monitor vaccine safety and update recommendations based on evolving data.
